Kwality Pharmaceuticals

Sector: Healthcare

Followers

0
0
0
0
.
0
0
2
2
1
1
,
1
1
18.55 (1.68%)

As on 29 Dec, 2025 | 16:01

Open Trading A/c
Day Range
1,057.45
1,200.00
LH
52 Week Range
596.05
1,235.00
LH
Volume
* i
Bid / Ask
15,291.00
0.00 / 0.00

Kwality Pharmaceuticals Announcements

Intimation of Closure of Trading Window

26 Dec, 2025 | 05:43pm • Source: BSE

Intimation of Change in name of Managing Director of the Company.

01 Dec, 2025 | 06:33pm • Source: BSE

Successful completion of the EU-GMP Audit at its Amritsar General and Beta Lactam Units

06 Nov, 2025 | 11:12am • Source: BSE

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and...

05 Nov, 2025 | 03:48pm • Source: BSE

Certificate under Regulation 74(5) of SEBI (DP) REGULATIONS, 2018 for the quarter ended 30-09-2025.

11 Oct, 2025 | 01:54pm • Source: BSE

E-Voting Results and Scrutinizer Report of 42nd AGM

11 Sep, 2025 | 02:07pm • Source: BSE

Regularization and Reappointment of Directors at AGM

10 Sep, 2025 | 06:55pm • Source: BSE

Appointment of Secretarial Auditor

09 Sep, 2025 | 11:04pm • Source: BSE

Proceedings of 42nd AGM are enclosed herewith

09 Sep, 2025 | 08:31pm • Source: BSE

Kwality Pharma receives product registration for Bleomycin 15 IU In Mexico for sale and distribution

18 Aug, 2025 | 11:35am • Source: BSE

Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('' Listing Regulations''), please find attached herewith the Annual Report of...

16 Aug, 2025 | 11:55pm • Source: BSE

Book Closure

16 Aug, 2025 | 10:26pm • Source: BSE

This is to inform you under Regulation 30 and any other regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the Board of...

16 Aug, 2025 | 08:59pm • Source: BSE

Unaudited financial results for q.e. 30-06-2025 are enclosed herewith

11 Aug, 2025 | 02:22pm • Source: BSE

We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and...

11 Aug, 2025 | 02:10pm • Source: BSE

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and...

04 Aug, 2025 | 05:18pm • Source: BSE

Resignation of Mr. Kiran Kumar Verma as Independent Director of the company

26 Jul, 2025 | 06:29pm • Source: BSE

1. Appointment of Mr. Vinod Kumar Sharma as Additional, non executive Independent director of the company2. Resignation of Mr. Kiran Kumar Verma as Independent...

26 Jul, 2025 | 06:26pm • Source: BSE

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30-06-2025.

14 Jul, 2025 | 12:40pm • Source: BSE